Jazz Pharma Balance Sheet - Annual (NASDAQ:JAZZ)

Add to My Stocks
$161.01 $2.06 (1.26%) JAZZ stock closing price Sep 17, 2018 (Closing)

A balance sheet is one of the three key financial statements released by a publicly listed company like Jazz Pharma, and helps in stock analysis. Financial strength can be guaged by performing Jazz Pharma stock analysis and by analyzing the balance sheet. Good annual results indicate a company's strong financial performance. Its important to check all financial statements including the balance sheet. Jazz Pharma balance sheet indicates an asset turnover ratio of 0.38 and debt to equity ratio of 0.56. Also check Jazz Pharma revenue and Jazz Pharma operating cash flow for the same period.

View latest 10 year balance sheet data to check Jazz Pharma financial performance.
show more
View Previous Years
View Next Years
Fiscal year is Jan - Dec2017201620152014201320122011201020092008
Marketable Securities215M60M----75.82M--1M
Raw Materials3.54M1.54M2.6M3.57M4.9M9.17M1.93M2.98M1.24M2.17M
Work In Progress15.69M18.68M11.83M9.87M8.9M1.21M----
Finished Goods24.01M13.81M5M16.59M14.86M16.13M1.44M1.35M1.5M2.45M
Notes Receivable----------
Other Current Assets99.86M53.81M39.74M115.39M74.63M62.37M2.95M2.13M2.63M4.74M
Total Current Assets
Property Plant & Equipment211.28M139.63M109.25M73.55M24.85M15.06M8.14M6.92M6.51M6.49M
Accumulated Depreciation41.2M32.14M23.68M15.19M10.61M7.77M6.58M6.23M5.38M3.98M
Net Property Plant & Equipment
Investment & Advances----------
Other Non-Current Assets----------
Deferred Charges42.23M24.79M146.13M108.66M89.2M91.42M----
Deposits & Other Assets16.41M14.06M27.54M15.93M7.3M3.66M--1.24M-
Total Assets
Notes Payable----------
Accounts Payable24.36M22.41M21.8M25.12M21M15.88M5.12M3.04M2.15M5.73M
Current Portion Long-Term Debt40.6M36.09M37.58M9.42M5.57M29.68M-23.41M33.15M122.4M
Current Portion Capital Leases----------
Accrued Expenses198.77M193.26M164.07M164.09M119.71M104.66M34.78M23.57M14.29M19.02M
Income Taxes Payable21.57M4.5M1.8M17.01M6.59M40.15M----
Other Current Liabilities8.61M1.12M1.37M1.13M51.13M1.13M12.95M9.9M9.62M26.32M
Total Current Liabilities
Deferred Taxes/Income399.58M559.33M298.2M379.55M174.21M185.16M7.91M9.13M10.22M11.33M
Convertible Debt----------
Long-Term Debt1.54B1.99B1.17B1.33B544.4M427.07M-24.62M91.1M-
Non-Current Capital Leases----------
Other Long-Term Liabilities176.6M112.61M69.25M38.39M20.04M41.42M-11.47M19.65M25.55M
Total Liabilities
Minority Interest----------
Preferred Stock----------
Common Stock Net----------
Capital Surplus1.94B1.67B1.56B1.46B1.22B1.15B542.69M505.41M434.81M407.92M
Retained Earnings918.42M529.37M303.15M34.7M18.53M-61.29M-349.88M-474.86M-507.64M-500.8M
Treasury Stock----------
Other Liabilities-140.87M-317.33M-267.47M-122.03M56.15M31.04M-0.03M---
Shareholders Equity2.71B1.88B1.6B1.37B1.3B1.12B192.78M30.55M-72.83M-92.87M
Total Liabilities & Shareholders Equity5.12B4.8B3.36B3.34B2.24B1.97B253.57M135.72M107.39M117.49M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

Apart from balance sheet items, an investor would do well to keep track of the Jazz Pharma stock price by looking at Jazz Pharma historical stock prices. One can compare PE with industry average by looking at the Jazz Pharma PE ratio chart. The common balance sheet items are:

  • Assets: JAZZ total assets, which was at $5.12B for 2017 is a balance sheet item representing value of what Jazz Pharma owns. Assets are brought to aid a firms operations, or to increase its economic value. It must be noted that tech stocks may not have a lot of assets, as the value for these companies is often derived from future earning potential.
  • Liabilities: This item on the balance sheet implies the firm's, in this case Jazz Pharma's, legal obligations including loans, accounts payable, deferred revenue, accrued expenses and mortgages. The total liabilities for JAZZ stock stand at $2.41B.

Jazz Pharma Balance Sheet - Key Ratios

Current ratio
Debt to equity ratio
Asset turnover ratio
Receivables turnover
Price to book ratio